ASSESS-3*: A randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan

International Journal of Impotence Research

Volumn 13, Issue 4, 2001, Pages 221-229

  Chen, K K ^a   Hsieh, J T ^b   Huang, S T ^c   Jiaan, D B P ^d   Lin, J S N ^e   Wang, C J ^f  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Efficacy; Erectile dysfunction; Safety; Sildenafil

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIRHEUMATIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC SEDATIVE AGENT; PLACEBO; SILDENAFIL;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; ERECTILE DYSFUNCTION; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; MULTICENTER STUDY; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; TAIWAN; TREATMENT OUTCOME; VERTIGO;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; COITUS; DOUBLE-BLIND METHOD; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SAFETY;

EID: 0034864622     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900685     Document Type: Article

References (28)

1. NIH Consensus Conference
2. Impotence and its medical and psychosexual correlates: Results of the Massachusetts Male Aging Study
3. The prevalence of erectile dysfunction in elder adults in Shanghai: An analysis of 1582 cases
4. Erectile dysfunction in Singapore men: Presentation, diagnosis, treatment and results
5. Update on male erectile dysfunction
6. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
7. Treatment of men with erectile dysfunction with transurethral alprostadil
8. Oral and topical treatment of erectile dysfunction. Present and future
9. Double-blind trial of yohimbine in treatment of psychogenic impotence
10. Trazodone, a double blind trial for treatment of erectile dysfunction
11. Effect of yohimbine-trazodone on psychogenic impotence: A randomized, double-blind, placebo-controlled study
12. Oral phentolamine as treatment for erectile dysfunction
13. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
14. Oral sildenafil in the treatment of erectile dysfunction
15. Sildenafil, a novel effective oral therapy for male erectile dysfunction
16. Long-term efficacy and safety of sildenafil (Viagra™): A 6-month, randomized, double-blind, placebo-controlled study in men with erectile dysfunction (ED)
17. Sildenafil (Viagra™), an oral treatment for erectile dysfunction (ED): A 12-week, double-blind, placebo-controlled study
18. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: A double-blind, placebo-controlled study of 329 patients
19. Treatment of erectile dysfunction with sildenafil
20. Sildenafil: Study of a novel oral treatment for erectile dysfunction in diabetic men
21. Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury
22. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction
23. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)
24. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction
25. Role of nitric oxide in the physiology of erection
26. Cross-cultural adaptation of the International Index of Erectile Function (IIEF)
27. Clinical safety of oral sildenafil citrate (Viagra™) in the treatment of erectile dysfunction
28. Use of sildenafil (Viagra) in patients with cardiovascular disease